Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
animal testing
CRO
Charles River to cuts costs, shift direction as revenue slides
The CRO giant plans to shed “underperforming or non-core” parts of its business while investing in animal testing alternatives.
Darren Incorvaia
Nov 5, 2025 12:54pm
Former FDA deputy to guide Charles River animal testing strategy
Oct 15, 2025 10:00am
NIH earmarks $87M for new organoid center
Sep 25, 2025 11:55am
Big Pharma-backed program seeks future beyond animal testing
Aug 1, 2025 5:00pm
Charles River launches strategic review, shakes up board
May 7, 2025 11:14am
NIH announces new office, plan to shift away from animal models
Apr 30, 2025 5:00pm
